J. Doty

erbB-2 oncogene inhibition by geldanamycin derivatives: synthesis, mechanism of action, and structure-activity relationships.

P. Miller, C. Diorio, M. Dee, 1995, Journal of medicinal chemistry.

Inhibition of the oncogene product p185erbB-2 in vitro and in vivo by geldanamycin and dihydrogeldanamycin derivatives.

C. Diorio, M. Dee, J. Moyer, 1995, Journal of medicinal chemistry.

A rational chemical intervention strategy to circumvent bioactivation liabilities associated with a nonpeptidyl thrombopoietin receptor agonist containing a 2-amino-4-arylthiazole motif.

G. S. Walker, A. Kalgutkar, A. Mutlib, 2007, Chemical research in toxicology.

Induction of apoptosis and cell cycle arrest by CP-358,774, an inhibitor of epidermal growth factor receptor tyrosine kinase.

L. Pustilnik, P. Miller, B. Boman, 1997, Cancer research.

Inhibition of epidermal growth factor receptor-associated tyrosine phosphorylation in human carcinomas with CP-358,774: dynamics of receptor inhibition in situ and antitumor effects in athymic mice.

L. Pustilnik, M. Morin, T. Smolarek, 1999, The Journal of pharmacology and experimental therapeutics.

Relationship between intrinsic radiation sensitivity and metastatic potential.

F. S. Pardo, M. Su, A. Lewis, 1996, International journal of radiation oncology, biology, physics.